Yan Lin

机构：Fujian Medical University, Nantong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Affiliated Hospital of Nantong University, Fujian Institute of Microbiology, Fosun Pharma (China), First Affiliated Hospital of Fujian Medical University, Fujian Provincial Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0009-0005-9357-4832

发表论文 224 篇 · 总被引 2961 次 · h-index 27

代表论文

• First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer (2025 · JAMA · 被引 72)
• Epithelial-mesenchymal plasticity (EMP) in wound healing: Exploring EMT mechanisms, regulatory network, and therapeutic opportunities (2024 · Heliyon · 被引 44)
• Single-domain antibody-based protein degrader for synucleinopathies (2024 · Molecular Neurodegeneration · 被引 13)
• Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions (2025 · Molecular Medicine · 被引 11)
• Neuronal hypofunction and network dysfunction in a mouse model at an early stage of tauopathy (2024 · Alzheimer s & Dementia · 被引 6)
• The impact of preference signaling on interview and match rate for surgical match in resident education: a meta-analysis (2025 · BMC Medical Education · 被引 5)